“As commissioner, my highest initial priority is to take immediate steps to reduce the scope of the epidemic of opioid addiction. I believe the Food and Drug Administration continues to have an important role to play in addressing this crisis, particularly when it comes to reducing the number of new cases of addiction,” Scott Gottlieb writes in blog post.
Among NCPA’s comments were notes about what it sees as the need to address direct and indirect remuneration, or DIR, fees; requests to standardize how Medicare Part D plans measure pharmacy quality; and other efforts to improve patient access to medication and pharmacy services
Clinical abstracts from the studies being presented focus primarily on Walgreens’ efforts to improve medication adherence and patient outcomes through various pharmacy initiatives.
It’s hard to argue against making sure every American has basic health insurance. The reality is that Americans have been paying through the nose for years to cover the costs of the uninsured that go without routine, basic care only to wind up later in the emergency room, or on the operating table.
The Journal of the American Geriatric Society has projected that the cost for the first year of hearing loss treatment in older adults will reach $51 billion nationwide by 2030.
The Natural Products Association on Tuesday expressed support of the reorganization of the Office of Regulatory Affairs by FDA.
In Kalorama’s most recent report on retail clinics, the company estimated there were more than 2,200 retail clinics and that those clinics will generate revenues of $1.4 billion this year.
Steve Anderson participated in a listening session, one of a series of events intended to gather information and policy ideas from a wide variety of stakeholders which relate to the affordability, accessibility and availability of drugs for patients.
Maine Sen. Susan Collins told the news outlet it was approved May 11 Collins says the measure is part of an investigation into "aggressive price hikes" in prescription drugs.
The NCPA letter to Republican Seantors cites research that a leading predictor of adherence is a patient’s proximity to and relationship with a pharmacist.